Nanoteknoloji ve Antimikrobiyal Direnç
Özet
Antimikrobiyal direnç (AMD), 21. yüzyılın en kritik küresel sağlık tehditlerinden biri olarak, 2050 yılına kadar 39 milyondan fazla ölüme neden olma potansiyeli taşımaktadır. Geleneksel antibiyotiklerin etkinliğindeki progresif azalma ve yeni antimikrobiyal ajanların geliştirilmesindeki intrinsik zorluklar, alternatif terapötik stratejilerin acil ihtiyacını ortaya çıkarmıştır.
Nanoteknoloji, benzersiz fizikokimyasal özellikleri ve çoklu etki mekanizmaları vasıtasıyla bu mücadelede transformatif bir paradigma sunmaktadır. Nanopartiküller, reaktif oksijen türleri (ROS) indüksiyonu, hücre membranı tahribatı, metal iyon salınımı ve enzimatik inhibisyon gibi multifaktöriyal mekanizmalar aracılığıyla antimikrobiyal aktivite göstermektedir. Bu yaklaşım, geleneksel antibiyotiklerin tek hedefli etki mekanizmalarının aksine, bakteriyel direnç gelişimini minimize etme potansiyeli taşımaktadır.
Nanoteknolojik uygulamalar, çoklu ilaca dirençli patojenlere karşı etkili tedavi seçenekleri, hedefe yönelik ilaç salım sistemleri ve biyofilm penetrasyonu gibi kritik avantajlar sağlamaktadır. Ancak, nanotoksikolojik endişeler, düzenleyici belirsizlikler ve ölçeklenebilir üretim zorlukları klinik translasyonun önündeki temel engellerdir. Multidisipliner yaklaşımlar ve sorumlu inovasyon stratejileriyle, nanoteknoloji AMD'ye karşı mücadelede paradigmatik dönüşüm sağlayabilecek potansiyele sahiptir.
Antimicrobial resistance (AMD) represents one of the most critical global health threats of the 21st century, with the potential to cause over 39 million deaths by 2050. The progressive decline in the efficacy of conventional antibiotics and the intrinsic challenges in developing novel antimicrobial agents have necessitated the urgent need for alternative therapeutic strategies.
Nanotechnology offers a transformative paradigm in this battle through its unique physicochemical properties and multifaceted mechanisms of action. Nanoparticles exhibit antimicrobial activity through multifactorial mechanisms including reactive oxygen species (ROS) induction, cell membrane disruption, metal ion release, and enzymatic inhibition. This approach holds the potential to minimize bacterial resistance development, in contrast to the single-target mechanisms of conventional antibiotics.
Nanotechnological applications provide critical advantages such as effective treatment options against multidrug-resistant pathogens, targeted drug delivery systems, and biofilm penetration capabilities. However, nanotoxicological concerns, regulatory uncertainties, and scalable production challenges constitute fundamental barriers to clinical translation. Through multidisciplinary approaches and responsible innovation strategies, nanotechnology possesses the potential to enable paradigmatic transformation in the fight against AMD.
Referanslar
World Health Organization. No time to wait: Securing the future from drug-resistant infections. 2019. (25/05/2025 tarihinde https://www.who.int/publications/i/item/no-time-to-wait-securing-the-future-from-drug-resistant-infections adresinden ulaşılmıştır).
Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet. 2022;399(10325): 629–655. doi.org/10.1016/S0140-6736(21)02724-0
Zhu X, Tang Q, Zhou X, et al. Antibiotic resistance and nanotechnology: a narrative review. Microbial Pathogenesis, 2024;106741. doi.org/10.1016/j.micpath.2024.106741
Mondal SK, Chakraborty S, Manna S, et al. Antimicrobial nanoparticles: current landscape and future challenges. RSC Pharmaceutics. 2024;1(3): 388–402. doi.org/10.1039/D4PM00032C
Kamat S, Kumari M. Emergence of microbial resistance against nanoparticles: Mechanisms and strategies. Front Microbiol. 2023;14: 1102615. doi.org/10.3389/fmicb.2023.1102615
Baveloni FG, Meneguin AB, SAbio RM, et al. Antimicrobial effect of silver nanoparticles as a potential healing treatment for wounds contaminated with Staphylococcus aureus in wistar rats. J Drug Deliv Sci Technol. 2025;106: 106445. doi.org/10.1016/j.jddst.2024.106445
Beyth N, Houri-Haddad Y, Domb A, et al. Alternative antimicrobial approach: Nano-antimicrobial materials. Evid Based Complement Alternat Med. 2015;2015: 246012. doi.org/10.1155/2015/246012
Zazo H, Colino CI, Lanao JM. Current applications of nanoparticles in infectious diseases. J Control Release. 2016;224: 86–102. doi:10.1016/j.jconrel.2016.01.008
Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016;4(2): VMBF-0016-2015. doi.org/10.1128/microbiolspec.VMBF-0016-2015
Foster TJ. Antibiotic resistance in Staphylococcus aureus: Current status and future prospects. FEMS Microbiol Rev. 2017;41(3): 430–449. doi.org/10.1093/femsre/fux007
Hooper DC, Jacoby GA. Topoisomerase inhibitors: Fluoroquinolone mechanisms of action and resistance. Cold Spring Harb Perspect Med. 2016;6(9): a025320. doi.org/10.1101/cshperspect.a025320
Goldstein BP. Resistance to rifampicin: A review. J Antibiot. 2014;67(9): 625–630. doi.org/10.1038/ja.2014.107
Fyfe C, Grossman TH, Kerstein K, et al. Resistance to macrolide antibiotics in public health pathogens. Cold Spring Harb Perspect Med. 2016;6(11): a025395. doi:10.1101/cshperspect.a025395
Courvalin P. Vancomycin resistance in Gram-positive cocci. Clin Infect Dis. 2006;42(Suppl 1): 25–34. doi:10.1086/491711
McKessar SJ, Berry AM, Bell JM, et al. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother. 2000;44(11): 3224–3228. doi:10.1128/AAC.44.11.3224-3228.2000
Lowy FD. Antimicrobial resistance: The example of Staphylococcus aureus. J Clin Invest. 2003;111(9): 1265–1273. doi:10.1172/JCI18535
Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother. 2005;56(1): 20–51. doi:10.1093/jac/dki171
Nikaido H, Pagès JM. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev. 2012;36(2): 340–363. doi:10.1111/j.1574-6976.2011.00290.x
Piddock LJV. Multidrug-resistance efflux pumps – not just for resistance. Nat Rev Microbiol. 2006;4(8): 629–636. doi:10.1038/nrmicro1464
Sharma A, Gupta VK, Pathania R. Efflux pump inhibitors for bacterial pathogens: From bench to bedside. Indian J Med Res. 2019;149(2): 129–145. doi:10.4103/ijmr.IJMR_2079_17
Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters. Nature. 2007;446(7137): 749–757. doi:10.1038/nature05630
Qin, L., Wenxu, C., Yidao, J., et al. Research Progress on the Structural Basis and Transport Mechanism of MFS Superfamily Transporters. Int J Front Med. 2024;6(11): 53–58. doi: 10.25236/IJFM.2024.061108
Shang Y, Zhang Y, Wang R, et al. Deciphering the molecular and functional basis of TMexCD1: the plasmid-encoded efflux pump of resistance-nodulation-division superfamily. Antimicrobial Agents and Chemotherapy. 2024;68(4):e01678-23. doi.org/10.1128/aac.01678-23
Anes J, McCusker MP, Fanning S, et al. The ins and outs of RND efflux pumps in Escherichia coli. Front Microbiol. 2015;6: 587. doi:10.3389/fmicb.2015.00587
Paulsen IT, Brown MH, Littlejohn TG, et al. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: Membrane topology and identification of residues involved in substrate specificity. Proc Natl Acad Sci U S A. 1996;93(8): 3630–3635. doi:10.1073/pnas.93.8.3630
Kuroda T, Tsuchiya T. Multidrug efflux transporters in the MATE family. Biochim Biophys Acta. 2009;1794(5): 763–768. doi:10.1016/j.bbapap.2008.11.012
Wright GD. Bacterial resistance to antibiotics: Enzymatic degradation and modification. Adv Drug Deliv Rev. 2005;57(10): 1451–1470. doi:10.1016/j.addr.2005.04.002
Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54(3): 969–976. doi:10.1128/AAC.01009-09
Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev. 2005;18(4): 657–686. doi:10.1128/CMR.18.4.657-686.2005
Queenan AM, Bush K. Carbapenemases: The versatile β-lactamases. Clinical Microbiology Reviews. 2007;20(3): 440–458. doi:10.1128/CMR.00001-07
Jacoby GA. AmpC β-lactamases. Clinical Microbiology Reviews. 2009;22(1): 161–182. doi:10.1128/CMR.00036-08
Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrobial Agents and Chemotherapy. 2010;54(1): 24–38. doi:10.1128/AAC.01512-08
Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resistance Updates. 2010;13(6): 151–171. doi:10.1016/j.drup.2010.08.003
Jeong Y, Ahmad S, Irudayaraj J. Dynamic effect of β-lactam antibiotic inactivation due to the inter-and intraspecies interaction of drug-resistant microbes. ACS Biomaterials Science & Engineering. 2024;10(3): 1461–1472. doi.org/10.1021/acsbiomaterials.3c01678
Algadi H, Alhoot MA, Al-Maleki AR, et al. Effects of metal and metal oxide nanoparticles against biofilm-forming bacteria: a systematic review. Journal of Microbiology and Biotechnology. 2024;34(9):1748. doi.org/10.4014/jmb.2403.03029
Flemming HC. EPS—then and now. Microorganisms. 2016;4(4): 41. doi.org/10.3390/microorganisms4040041
Dufour D, Leung V, Lévesque CM. Bacterial biofilm: structure, function, and antimicrobial resistance. Endodontic Topics. 2010;22(1): 2–16. doi.org/10.1111/j.1601-1546.2012.00277.x
Yu Y, Zhang Y, Cheng Y, et al. NIR-activated nanosystems with self-modulated bacteria targeting for enhanced biofilm eradication and caries prevention. Bioactive Materials. 2022;13: 269–285. doi.org/10.1016/j.bioactmat.2021.10.035
Jo J, Price-Whelan A, Dietrich LE. Gradients and consequences of heterogeneity in biofilms. Nature Reviews Microbiology. 2022;20(10): 593–607. doi.org/10.1038/s41579-022-00692-2
Yan J, Bassler BL. Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms. Cell Host & Microbe. 2019;26(1): 15–21. doi.org/10.1016/j.chom.2019.06.002
Michaelis C, Grohmann E. Horizontal gene transfer of antibiotic resistance genes in biofilms. Antibiotics. 2023;12(2): 328. doi.org/10.3390/antibiotics12020328
Gambino M, Cappitelli F. Mini-review: Biofilm responses to oxidative stress. Biofouling. 2016;32(2): 167–178. doi.org/10.1080/08927014.2015.1134515
Wilton M, Charron-Mazenod L, Moore R, Lewenza S. Extracellular DNA acidifies biofilms and induces aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 2016;60(1): 544–553. doi.org/10.1128/AAC.01650-15
Xie M, Gao M, Yun Y, et al. Antibacterial nanomaterials: mechanisms, impacts on antimicrobial resistance and design principles. Angewandte Chemie International Edition. 2023;62(17): e202217345. doi.org/10.1002/anie.202217345
Dakal TC, Kumar A, Majumdar RS, Yadav V. Mechanistic basis of antimicrobial actions of silver nanoparticles. Frontiers in Microbiology. 2016;7: 1831. doi:10.3389/fmicb.2016.01831
Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Advanced Drug Delivery Reviews. 2013;65(13–14): 1803–1815. doi:10.1016/j.addr.2013.07.011
Slavin YN, Ivanova K, Hoyo J, et al. Novel lignin-capped silver nanoparticles against multidrug-resistant bacteria. ACS Applied Materials & Interfaces. 2021;13(19): 22098–22109. doi.org/10.1021/acsami.0c16921
Gao X, Yi X, Liu Z, et al. Comparative study on curcumin loaded in golden pompano (Trachinotus blochii) head phospholipid and soybean lecithin liposomes: Preparation, characteristics and anti-inflammatory properties. Molecules. 2021;26(8): 2328. doi.org/10.3390/ molecules26082328
Singh R, Lillard Jr JW. Nanoparticle-based targeted drug delivery. Experimental and Molecular Pathology. 2009;86(3): 215-223. doi.org/10.1016/j.yexmp.2008.12.004
Liu CC, Yeung CY, Chen PH, et al. Salmonella detection using 16S ribosomal DNA/RNA probe-gold nanoparticles and lateral flow immunoassay. Food Chemistry. 2013;141(3): 2526-2532. doi.org/10.1016/j.foodchem.2013.05.089
Feng W, Li G, Kang X, et al. Cascade‐targeting poly(amino acid) nanoparticles eliminate intracellular bacteria via on‐site antibiotic delivery. Advanced Materials. 2022;34(12): 2109789. doi.org/10.1002/adma.202109789
Sirelkhatim A, Mahmud S, Seeni A, et al. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Letters. 2015;7: 219–242. doi.org/10.1007/s40820-015-0040-x
Singh AK, Tiwari R, Kumar V, et al. Photo-induced biosynthesis of silver nanoparticles from aqueous extract of Dunaliella salina and their anticancer potential. Journal of Photochemistry and Photobiology B: Biology. 2017;166: 202–211. doi.org/10.1016/j.jphotobiol.2016.11.020
Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine: Nanotechnology, Biology and Medicine. 2007;3(2): 168–171. doi.org/10.1016/j.nano.2007.02.001
Díez-Pascual AM. Antibacterial activity of nanomaterials. Nanomaterials. 2018;8(6): 359. doi.org/10.3390/nano8060359
Wang Z, Wang M, Wang X, et al. Photothermal-based nanomaterials and photothermal-sensing: An overview. Biosensors and Bioelectronics. 2023;220: 114883. doi.org/10.1016/j.bios.2022. 114883
Palmieri B, Siviello C, Petriccione A, et al. Mechanical and viscoelastic properties of carbon fibre epoxy composites with interleaved graphite nanoplatelet layer. Journal of Composites Science. 2023;7(6): 235. doi.org/10.3390/jcs7060235
Díez-Pascual AM. State of the art in the antibacterial and antiviral applications of carbon-based polymeric nanocomposites. International Journal of Molecular Sciences. 2021;22(19):10511. doi.org/10.3390/ijms221910511
Shao L, Wang C, Xu G, et al. Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: A review. Open Medicine. 2024;19(1): 20241041. doi.org/10.1515/med-2024-1041
Seregina TA, Lobanov KV, Shakulov RS, et al. Enhancement of the bactericidal effect of antibiotics by inhibition of enzymes involved in production of hydrogen sulfide in bacteria. Molecular Biology. 2022;56(5): 638-648. doi.org/10.1134/S0026893322050120
Liu Y, Liu J. Leakage and rupture of lipid membranes by charged polymers and nanoparticles. Langmuir. 2020;36(3): 810-818. doi.org/10.1021/acs.langmuir.9b03301
Puri A, Loomis K, Smith B, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2009;26(6). doi.org/10.1615/CritRevTherDrugCarrierSyst.v26.i6.10
Lee MK. Liposomes for enhanced bioavailability of water-insoluble drugs: In vivo evidence and recent approaches. Pharmaceutics. 2020;12(3): 264. doi.org/10.3390/pharmaceutics12030264
Cantor S, Vargas L, Rojas A OE, et al. Evaluation of the antimicrobial activity of cationic peptides loaded in surface-modified nanoliposomes against foodborne bacteria. International Journal of Molecular Sciences. 2019;20(3): 680. doi.org/10.3390/ijms20030680
Bakker-Woudenberg IA. Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci. International Journal of Antimicrobial Agents. 2002;19(4): 299-311. doi.org/10.1016/S0924-8579(02)00021-3
Muppidi K, Wang J, Betageri G, et al. PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin. Antimicrobial Agents and Chemotherapy. 2011;55(10): 4537-4542. doi.org/10.1128/AAC.00713-11
García-Pinel B, Porras-Alcalá C, Ortega-Rodríguez A, et al. Lipid-based nanoparticles: application and recent advances in cancer treatment. Nanomaterials. 2019;9(4): 638. doi.org/10.3390/nano9040638
Wilczewska AZ, Niemirowicz K, Markiewicz KH, et al. Nanoparticles as drug delivery systems. Pharmacological Reports. 2012;64(5): 1020-1037. doi.org/10.1016/S1734-1140(12)70901-5
Liu Y, Xiao Y, Cao Y, et al. Construction of chitosan‐based hydrogel incorporated with antimonene nanosheets for rapid capture and elimination of bacteria. Advanced Functional Materials. 2020;30(35): 2003196. doi.org/10.1002/adfm.202003196
Kamaly N, Yameen B, Wu J, et al. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chemical Reviews. 2016;116(4): 2602-2663. doi.org/10.1021/acs.chemrev.5b00346
Bibi F, Ahmad I, Hussain S, et al. Synergistic effect of graphene oxide and silica nanocomposites towards multifunctional biomedical applications. Ceramics International. 2024;50(24): 53319-53328. doi.org/10.1016/j.ceramint.2024.10.182
Courtney CM, Goodman SM, McDaniel JA, et al. Photoexcited quantum dots for killing multidrug-resistant bacteria. Nature Materials. 2016;15(5): 529-534. doi.org/10.1038/nmat4542
Probst J, Dembski S, Milde M, et al. Luminescent nanoparticles and their use for in vitro and in vivo diagnostics. Expert Review of Molecular Diagnostics. 2012;12(1): 49-64. doi.org/10.1586/erm.11.86
Hagbani TA, Yadav H, Moin A, et al. Enhancement of vancomycin potential against pathogenic bacterial strains via gold nano-formulations: A nano-antibiotic approach. Materials. 2022;15(3): 1108. doi.org/10.3390/ma15031108
Pateiro M, Gómez B, Munekata PE, et al. Nanoencapsulation of promising bioactive compounds to improve their absorption, stability, functionality and the appearance of the final food products. Molecules. 2021;26(6): 1547. doi.org/10.3390/molecules26061547
Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Advanced Drug Delivery Reviews. 2013;65(13-14): 1803-1815. doi.org/10.1016/j.addr.2013.07.011
Khare T, Mahalunkar S, Shriram V, et al. Embelin-loaded chitosan gold nanoparticles interact synergistically with ciprofloxacin by inhibiting efflux pumps in multidrug-resistant Pseudomonas aeruginosa and Escherichia coli. Environmental Research. 2021;199: 111321. doi.org/10.1016/j.envres.2021.111321
Filby BW, Weldrick PJ, Paunov VN. Overcoming beta-lactamase-based antimicrobial resistance by nanocarrier-loaded clavulanic acid and antibiotic cotreatments. ACS Applied Bio Materials. 2022;5(8): 3826-3840. doi.org/10.1021/acsabm.2c00369
Li P, Chen X, Shen Y, et al. Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm. Journal of Controlled Release. 2019;300: 52-63. doi.org/10.1016/j.jconrel.2019.02.039
Darienzo RE, Chen O, Sullivan M, et al. Au nanoparticles for SERS: Temperature-controlled nanoparticle morphologies and their Raman enhancing properties. Materials Chemistry and Physics. 2020;240: 122143. doi.org/10.1016/j.matchemphys.2019.122143
Makwana M, Patel AM. Identification of microbes using single-layer graphene-based nano biosensors. Journal of Molecular Modeling. 2023;29(12): 382. doi.org/10.1007/s00894-023-05748-5
Abdou Mohamed MA, Kozlowski HN, Kim J, et al. Diagnosing antibiotic resistance using nucleic acid enzymes and gold nanoparticles. ACS Nano. 2021;15(6): 9379-9390. doi.org/10.1021/acsnano.0c09902
Tang C, He Z, Liu H, et al. Application of magnetic nanoparticles in nucleic acid detection. Journal of Nanobiotechnology. 2020;18: 1-19. doi.org/10.1186/s12951-020-00613-6
Chen Y, Xianyu Y, Wang Y, et al. One-step detection of pathogens and viruses: combining magnetic relaxation switching and magnetic separation. ACS Nano. 2015;9(3): 3184-3191. doi.org/10.1021/acsnano.5b00240
Wang Y, Zhao Y, Bollas A, et al. Nanopore sequencing technology, bioinformatics and applications. Nature Biotechnology. 2021;39(11): 1348-1365. doi.org/10.1038/s41587-021-01108-x
Zhang X, Shi Y, Chen G, et al. CRISPR/Cas systems‐inspired nano/biosensors for detecting infectious viruses and pathogenic bacteria. Small Methods. 2022;6(10): 2200794. doi.org/10.1002/smtd.202200794
Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives. 2005;113(7): 823-839. doi.org/10.1289/ehp.7339
Hristozov D, Gottardo S, Semenzin E, et al. Frameworks and tools for risk assessment of manufactured nanomaterials. Environment International. 2016;95: 36-53. doi.org/10.1016/j.envint.2016.07.016
Xuan L, Ju Z, Skonieczna M, et al. Nanoparticles‐induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models. MedComm. 2023;4(4): e327. doi.org/10.1002/mco2.327
AshaRani PV, Low Kah Mun G, Hande MP, et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3(2): 279-290. doi.org/10.1021/nn800596w
Valdiglesias V. Cytotoxicity and genotoxicity of nanomaterials. Nanomaterials. 2022;12(4): 634. doi.org/10.3390/nano12040634
Engin AB, Hayes AW. The impact of immunotoxicity in evaluation of the nanomaterials safety. Toxicology Research and Application. 2018;2: 2397847318755579. doi.org/10.1177/2397847318755579
Sramkova M, Kozics K, Masanova V, et al. Kidney nanotoxicity studied in human renal proximal tubule epithelial cell line TH1. Mutat Res Gen Tox En. 2019;845: 403017. doi.org/10.1016/j.mrgentox.2019.01.012
Kahru A, Dubourguier HC. From ecotoxicology to nanoecotoxicology Toxicology. 2010;269(2-3): 105-119. doi.org/10.1016/j.tox.2009.08.016
Boran F. Encapsulation of CuO nanoparticles inside the channels of the multi-walled carbon nanotubes functionalized with thermal stress. Diamond and Related Materials. 2021;114: 108306. doi.org/10.1016/j.diamond.2021.108306
Monopoli MP, Aberg C, Salvati A, et al. Biomolecular coronas provide the biological identity of nanosized materials. Nano-enabled Medical Applications. 2020: 205-229. doi.org/10.1038/nnano.2012.207
Churilov DG, Polischuk SD, Churilov GI, et al. Investigation of the long-term toxic effect of nanoparticles of different physical-chemical characteristics. Agronomy Research. 2020:18(3): 1973-1991. doi.org/10.15159/AR.20.186
FDA (Food and Drug Administration). Drug Products, Including Biological Products, that Contain Nanomaterials Guidance for Industry. 2022. (22/05/2025 tarihinde https://www.fda.gov/media/157812/download?attachment adresinden ulaşılmıştır).
Elzein B. Nano revolution: "Tiny tech, big impact: how nanotechnology is driving SDGs progress. Heliyon. 2024;10(10). doi.org/10.1016/j.heliyon.2024.e31393
